Ignite Creation Date:
2025-12-24 @ 7:03 PM
Ignite Modification Date:
2026-02-18 @ 12:23 PM
Study NCT ID:
NCT03317457
Status:
COMPLETED
Last Update Posted:
2023-06-15
First Post:
2017-10-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Durvalumab and Tremelimumab Compared to Doxorubicin in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Sponsor:
AIO-Studien-gGmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-12
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-18
First Submit QC Date:
None
Study First Post Date:
2017-10-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-14
Last Update Post Date:
2023-06-15
Last Update Post Date Type:
ACTUAL